linkedin.enzyme.finance

DNS Records

Tailwind CSS

Web Framework

LinkedIn

Social Media

Services

enzymefinance

LinkedIn

Social media

JSON+LD

{
  "@context": "http://schema.org",
  "@graph": [
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-09-09T15:24:45.379Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_62m-notional-27m-in-premiums-enzymemyso-activity-7371201908973318144-fLJd",
      "text": "$62M+ notional. $2.7M+ in premiums. 📈\n\nEnzyme.Myso is what on-chain options look like at scale. Learn more: https://lnkd.in/dCygNj9c",
      "url": "https://www.linkedin.com/posts/enzymefinance_62m-notional-27m-in-premiums-enzymemyso-activity-7371201908973318144-fLJd"
    },
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-09-06T10:35:28.332Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_enzymeonyx-is-changing-the-question-from-activity-7370041944661581824-QmH-",
      "text": "Enzyme.Onyx is changing the question from “can we?” to “how far can we go?”\n\nBuilt for the innovators of modern markets, Enzyme.Onyx gives enterprises the freedom to create and manage fully tokenized strategies.\n\nExplore Enzyme.Onyx → https://lnkd.in/drC6n5Dq",
      "url": "https://www.linkedin.com/posts/enzymefinance_enzymeonyx-is-changing-the-question-from-activity-7370041944661581824-QmH-"
    },
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-09-02T15:34:25.246Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_businesses-manage-173m-using-enzymeblue-activity-7368667626056597505-Zyti",
      "text": "Businesses manage $173M+ using Enzyme​.Blue 📈\n\nFrom asset managers to institutions, Enzyme is powering onchain asset management at scale.\n\nTry Enzyme​.Blue today: https://lnkd.in/dTa8RZWN",
      "url": "https://www.linkedin.com/posts/enzymefinance_businesses-manage-173m-using-enzymeblue-activity-7368667626056597505-Zyti"
    },
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-08-28T15:17:51.861Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_tokenization-is-step-one-composability-is-activity-7366851520136482819-7vHT",
      "text": "Tokenization is step one. Composability is what takes it further.\n\nAt Enzyme, we make it possible not just to bring assets on-chain, but to do something meaningful with them.\n\nTake tokenized funds. They offer on-chain exposure to assets like tokenized AAPL, MSFT, etc., creating an ETF-like experience in a fully programmable environment.\n\nBut here’s where it gets interesting:\n→ You can automate strategies\n→ Customize fee flows\n→ Design cross-chain logic\n→ Rebalance and manage capital in real-time\n\nThis is tokenized finance, built as infrastructure. Let’s talk about building with programmable finance.\nhttps://lnkd.in/d-dHuVzj",
      "url": "https://www.linkedin.com/posts/enzymefinance_tokenization-is-step-one-composability-is-activity-7366851520136482819-7vHT"
    },
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-08-26T15:35:52.821Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_elevate-your-apps-offering-with-enzyme-activity-7366131278477246464-Nik2",
      "text": "Elevate your app’s offering with Enzyme 👋\n\nEnzyme helps you scale faster by embedding advanced financial products into the experiences your users already trust.\n\n• Distribute ready-to-deploy yield products\nBring institutional-grade strategies to your users with minimal effort by listing live Enzyme Vaults managed by experienced investors and businesses.\n\n• Develop financial instruments tailored for your customers\nWith Enzyme​.Blue and Enzyme.Onyx, you can distribute your Enzyme Vault in white-label to maximize reach and increase deposits tenfold.\n\n• Establish new revenue streams\nUse Enzyme​.Blue & Enzyme.Onyx to automate vaults for capital management, launchpads, or treasury ops. With Enzyme.Myso, use on-chain options, letting users write, sell & trade Covered Calls and Cash-Secured Puts natively.\n\nWith enterprise-grade infrastructure and white-label integrations, Enzyme empowers apps to create real value without rebuilding from scratch.\n\n🧬 Learn more →  https://lnkd.in/dSGvkvdt",
      "url": "https://www.linkedin.com/posts/enzymefinance_elevate-your-apps-offering-with-enzyme-activity-7366131278477246464-Nik2"
    },
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-08-24T12:35:40.950Z",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_how-telos-uses-onchain-options-for-its-treasury-activity-7365361154317004800-eMTV",
      "text": "How Telos uses onchain options for its treasury management 👇\n\nTelos, a high-performance blockchain built for scalability and low fees, wanted to diversify its treasury management tools and enhance yield generation. Telos leveraged Enzyme.Myso to structure tailored covered calls on wTLOS(wrapped Telos tokens).\n\nHere’s how it worked. Telos sold an option to buy approximately 300,000 wTLOS at a 110% strike price, with expiry in 30 days. The wTLOS remained securely locked in escrow during the term, enabling:\n・Telos to generate immediate income from the upfront premium\n・Retention of asset ownership throughout the option’s duration\n・Assurance for the option buyer that the wTLOS would be available on-chain at expiry\n\nThese covered calls were executed 100% on-chain and OTC, with Enzyme’s network of institutional market makers facilitating efficient execution. Telos arranged its strategy into three tranches, each earning premiums of ~6–7% upfront, successfully generating yield while retaining upside exposure.\n\nInterested in how it works? Check here: https://lnkd.in/dCygNj9c",
      "url": "https://www.linkedin.com/posts/enzymefinance_how-telos-uses-onchain-options-for-its-treasury-activity-7365361154317004800-eMTV"
    },
    {
      "@context": "http://schema.org",
      "@type": "DiscussionForumPosting",
      "author": {
        "@type": "Organization",
        "name": "Enzyme",
        "url": "https://www.linkedin.com/company/enzymefinance"
      },
      "datePublished": "2025-08-19T13:27:48.757Z",
      "headline": "",
      "mainEntityOfPage": "https://www.linkedin.com/posts/enzymefinance_thousands-of-vaults-already-run-on-enzymeblue-activity-7363562333937221633-3gOR",
      "text": "Thousands of vaults already run on Enzyme​.Blue 🧬 \n\nWhy? Because it makes onchain asset management simple, transparent, and automated.\n\nExplore the no-code vault creation: https://lnkd.in/dTa8RZWN",
      "url": "https://www.linkedin.com/posts/enzymefinance_thousands-of-vaults-already-run-on-enzymeblue-activity-7363562333937221633-3gOR"
    },
    {
      "@context": "http://schema.org",
      "@type": "Organization",
      "name": "Enzyme",
      "url": "https://www.linkedin.com/company/enzymefinance",
      "description": "Enzyme provides industry leaders with a comprehensive infrastructure to manage on-chain assets efficiently, optimize operational processes, and develop innovative financial strategies tailored to their unique goals and challenges",
      "numberOfEmployees": {
        "value": 17,
        "@type": "QuantitativeValue"
      },
      "logo": {
        "contentUrl": "https://media.licdn.com/dms/image/v2/D4E0BAQHl8xHN_v5A_w/company-logo_200_200/B4EZY0LJThHUAQ-/0/1744632059479/enzymefinance_logo?e=2147483647&v=beta&t=OA2uR1-rGgAeJCbBd7HHeYb1FYQaRPr5jc8tpjhNBC0",
        "description": "Enzyme",
        "@type": "ImageObject"
      },
      "slogan": "The global infrastructure for tokenized finance.",
      "sameAs": "https://enzyme.finance"
    }
  ]
}